Corneal Cross-Linking (CXL) for Therapy-Resistant Keratitis with Corneal Melting: It Is Never Too Late!

Background

Corneal ulcers are responsible for approximately 2 million new cases of corneal blindness annually and they are a leading cause of ocular morbidity worldwide [1]. Microbial keratitis requires aggressive management to limit the disease process and thereby minimize future visual disability. The empirical use of broad-spectrum antibiotics is contributing to a rise in multidrug-resistant bacteria, threatening the future treatment options of infectious keratitis [2].

• References

• 1 Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ 2001; 79: 214-221
• 2 Makdoumi K, Mortensen J, Sorkhabi O. et al. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 2012; 250: 95-102
• 3 Wei A, Wang K, Wang Y. et al. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol 2019; 257: 1443-1452
• 4 Ou JI, Acharya NR. Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 2007; 47: 7-16
• 5 Iseli HP, Thiel MA, Hafezi F. et al. Ultraviolet a/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 2008; 27: 590-594
• 6 Idrus EA, Utti EM, Mattila JS. et al. Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis. Acta Ophthalmol 2019; 97: 721-726 doi:10.1111/aos.14001
• 7 Belin MW, Lim L, Rajpal RK. et al. Corneal Cross-Linking: Current USA Status: Report from the Cornea Society. Cornea 2018; 37: 1218-1225
• 8 Abbouda A, Abicca I, Alió JL. Current and Future Applications of Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL): An Overview of the Different Treatments Proposed. Semin Ophthalmol 2018; 33: 293-299 doi:10.3109/08820538.2015.1123731
• 9 Özdemir HB, Kalkancı A, Bilgihan K. et al. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol 2019; 97: e91
• 10 Prajna NV, Radhakrishnan N, Lalitha P. et al. Cross-Linking – Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis. Ophthalmology 2020; 127: 159-166 doi:10.1016/j.ophtha.2019.08.029
• 11 Ting DSJ, Henein C, Said DG. et al. Photoactivated chromophore for infectious keratitis – Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis. Ocul Surf 2019; 17: 624-634 doi:10.1016/j.jtos.2019.08.006
• 12 Guber I, Bergin C, Majo F. Repeated Intrastromal Injections of Voriconazole in Combination with Corneal Debridement for Recalcitrant Fungal Keratitis – A Case Series. Klin Monatsbl Augenheilkd 2016; 233: 369-372